Back
Ares Capital Corp. 10K Form
Sell
7
ARCC
Ares Capital Corp.
Last Price:
$19.16
Seasonality Move:
2.23%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-01 | 10Q | ARCC/Ares Capital Corp. Quarterly |
| 2024-03-22 | 10K | ARCC/Ares Capital Corp. Annual |
| 2024-02-07 | 10K | ARCC/Ares Capital Corp. Annual |
| 2023-10-24 | 10Q | ARCC/Ares Capital Corp. Quarterly |
| 2023-07-25 | 10Q | ARCC/Ares Capital Corp. Quarterly |
| 2023-04-25 | 10Q | ARCC/Ares Capital Corp. Quarterly |
Receive ARCC News And Ratings
See the #1 stock for the next 7 days that we like better than ARCC
ARCC Financial Statistics
Sales & Book Value
| Annual Sales: | $3.1B |
|---|---|
| Cash Flow: | $248M |
| Price / Cash Flow: | 11.6 |
| Annual Sales: | $19.94 |
| Price / Book: | 0.95 |
Profitability
| EPS (TTM): | 1.85490 |
|---|---|
| Net Income (TTM): | $1.3B |
| Gross Margin: | $2.4B |
| Return on Equity: | 9.32% |
| Return on Assets: | 4.4% |
Ares Capital Corp. Earnings Forecast
Key Ares Capital Corp. Financial Ratios
-
The Gross Profit Margin over the past 14 years for ARCC is 75.68%.
-
The Selling, General & Administrative Expenses for ARCC have been equal to 0.00% of Gross Profit Margin.
-
The Interest Expense is 61.05% of Operating Income.
-
The Net Earning history of ARCC is 41.30% of Total Revenues.
-
Per Share Earnings over the last 22 years have been positive in 10 years.
Ares Capital Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Capital Markets |
| Sector: | Financials |
| Current Symbol: | ARCC |
| CUSIP: | 04010L |
| Website: | arescapitalcorp.com |
Debt
| Debt-to-Equity Ratio: | 1.12 |
|---|---|
| Current Ratio: | 1.71 |
| Quick Ratio: | 1.03 |
Price-to-Earnings
| Trailing P/E Ratio: | 10.2 |
|---|---|
| Forward P/E Ratio: | 9.86 |
ARCC Technical Analysis vs Fundamental Analysis
Sell
7
Ares Capital Corp. (ARCC)
is a Sell
Is Ares Capital Corp. a Buy or a Sell?
-
Ares Capital Corp. stock is rated a SellThe current Ares Capital Corp. [ARCC] share price is $18.95. The Score for ARCC is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.